HIGHLIGHTS
- who: Soumik Das from the School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India have published the paper: Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients, in the Journal: (JOURNAL)
- what: Their degradation has been the primary focus for the development of molecular therapies as TK inhibitors (TKIs), which target and block these enzymes, are crucial in the fight against different forms of cancer .
SUMMARY
Cervical cancer (CC) is one of the common cancers that affect women around the globe. Although . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.